MCAT Glycolysis: Step-by-Step Guide to the Ten Steps and Key Enzymes

Glycolysis is the starting point of nearly all energy metabolism pathways the MCAT tests. Glucose enters glycolysis regardless of whether oxygen is available. The pyruvate produced either feeds into the citric acid cycle (aerobic) or is converted to lactate or ethanol (anaerobic). This pathway bridges to almost everything else in cellular respiration — which is why MCAT questions about glycolysis often connect it to downstream pathways, disease states like lactic acidosis, or regulatory conditions like exercise or fasting.

You don't need to memorize every intermediate structure or enzyme by step number. What you need is: the net yield, the two regulated enzymes the MCAT specifically tests, where the pathway occurs, and what happens to pyruvate under different oxygen conditions.

Glycolysis occurs in the cytoplasm of all cells and converts one molecule of glucose (6 carbons) into two molecules of pyruvate (3 carbons each). The ten-step pathway splits into two functional phases.

The investment phase (steps 1–5) uses 2 ATP to activate the glucose molecule. Hexokinase (step 1) phosphorylates glucose to glucose-6-phosphate, trapping it inside the cell. Phosphofructokinase-1, or PFK-1 (step 3), phosphorylates fructose-6-phosphate to fructose-1,6-bisphosphate. This is the rate-limiting step — the most regulated point of the entire pathway. At the end of the investment phase, one 6-carbon molecule is split into two 3-carbon molecules.

The payoff phase (steps 6–10) generates 4 ATP and 2 NADH from each original glucose. Because 2 ATP were consumed in the investment phase, the net yield per glucose is 2 ATP, 2 NADH, and 2 pyruvate.

The net yield to memorize: 2 ATP (net), 2 NADH, 2 pyruvate.

Hexokinase (step 1) phosphorylates glucose → glucose-6-phosphate. It is product-inhibited — when G6P accumulates, hexokinase slows down. In the liver, glucokinase (isoform of hexokinase with lower affinity) performs the equivalent reaction and is not inhibited by G6P, allowing the liver to keep processing glucose even when intracellular G6P is high.

Phosphofructokinase-1 (PFK-1, step 3) is the rate-limiting enzyme and the primary regulatory checkpoint of glycolysis. PFK-1 is allosterically activated by AMP and ADP (low energy signal — speed up glycolysis) and by fructose-2,6-bisphosphate (F-2,6-BP, the most potent activator). It is allosterically inhibited by ATP and citrate (high energy signal — slow down glycolysis). The MCAT will ask about PFK-1 regulation repeatedly and in different ways.

Pyruvate kinase (step 10) converts phosphoenolpyruvate (PEP) to pyruvate and generates ATP. It is activated by fructose-1,6-bisphosphate (feedforward activation from earlier in the pathway) and inhibited by ATP and alanine (gluconeogenesis signal). In liver cells, pyruvate kinase is also regulated by glucagon (inhibits) and insulin (activates).

In aerobic conditions, pyruvate crosses into the mitochondrial matrix where pyruvate dehydrogenase converts it to acetyl-CoA, generating one NADH and releasing CO2 per pyruvate. Acetyl-CoA then enters the citric acid cycle.

In anaerobic conditions, cells run out of NAD+ (which gets consumed in step 6 of glycolysis and must be recycled). To keep glycolysis running, cells regenerate NAD+ by converting pyruvate to lactate (in muscle and red blood cells) via lactate dehydrogenase. This is anaerobic glycolysis — also called lactic acid fermentation in bacteria. The lactate is not a dead end; it can be transported to the liver and reconverted to glucose via gluconeogenesis (the Cori cycle).

In yeast and some other organisms, anaerobic fermentation converts pyruvate to ethanol and CO2 instead of lactate. This won't be tested in clinical contexts but may appear in biochemistry passages.

Glycolysis speeds up when energy is low (high AMP/ADP ratio) and slows down when energy is high (high ATP, high citrate). The master switch is PFK-1. When you see an MCAT question about conditions that increase or decrease glycolysis rate, work backward from PFK-1: does this condition activate or inhibit it?

Fasting and glucagon: glucagon promotes gluconeogenesis and inhibits glycolysis. Glucagon activates a signaling cascade that decreases fructose-2,6-bisphosphate levels, removing PFK-1's most potent activator.

Intense exercise: AMP accumulates as ATP is depleted, powerfully activating PFK-1 and accelerating glycolysis. This is why skeletal muscle can dramatically upregulate glucose use during vigorous exercise without requiring hormonal signaling.

Many MCAT glycolysis questions are embedded in a passage about a disease, drug, or metabolic condition. Common setups include: an enzyme deficiency (e.g., PFK-1 deficiency causing exercise intolerance), an inhibitor that blocks a specific step, a clinical scenario involving lactic acidosis, or a comparison between aerobic and anaerobic ATP yield.

The question will typically ask: what happens to a glycolytic intermediate when enzyme X is inhibited? Or: which enzyme is the rate-limiting step? Or: why does lactic acid accumulate under condition Y? For all of these, you need the pathway mechanics — specifically which enzyme is affected, what substrate accumulates upstream, and what downstream products are reduced.

Discrete questions (not passage-based) often test the net yield directly: 'How many net ATP are produced per glucose in glycolysis?' Answer: 2. Or: 'What cofactor is reduced in glycolysis?' Answer: NAD+ → NADH.